Latest content from Ingredients

Grain-Free Pet Food for Cats and Dogs
 
Pulses and Oilseeds

4+ MIN

Grain-Free Pet Food for Cats and Dogs  

WHAT ARE 'GRAIN-FREE' PET FOODS?
Pet foods that are sold as 'grain-free' typically do not contain grains. Grain-free foods typically contain ingredients such as pulses including beans, chickpeas, and lentils, and can also include tubers (e.g., potatoes). More recently, grain free pet foods have become a popular feeding choice for some pet owners.
  WHAT ARE GRAINS?
Grains (cereals) are a group of ingredients that contain mainly starch as well as varying amounts of protein, fibre, lipids, vitamins, and minerals and are used in pet foods. Grain examples include rice, corn, wheat, barley, sorghum and oats.   WHAT ARE PULSES?
Pulses are defined as the dried edible seeds of plants in the legume family1. Examples of pulses include dried beans, broad beans/faba beans, peas, chickpeas/garbanzo beans, and lentils. Pulses contain starch (typically at levels lower than cereals) as well as protein (at levels higher than cereals), fibre and some lipids, vitamins and minerals.   DOES 'GRAIN-FREE' MEAN CARBOHYDRATE FREE?
Carbohydrates, which include starches and fibres, are an important source of energy and promote digestive health. Carbohydrates are present in ingredients typically found in 'grain-free' recipes for instance in pulses (e.g., beans, chickpeas, lentils, etc.), potatoes, and sweet potatoes.

Starch plays a crucial role in the manufacture of dry pet food. For more information about the role of carbohydrates in pet food see the FEDIAF factsheet on carbohydrates2.
  WHAT IS GLUTEN AND WHERE DO YOU FIND IT?
Gluten is a type of protein. It is found in some cereal grains (wheat, barley, and rye). Gluten can be used to bind items together, such as in bread. Gluten is composed of two main proteins – glutenin and gliadin, with gliadin making up 70% of the protein content. Wheat gluten intolerance is very rare in dogs and has not been reported in cats. It is recommended to consult with your veterinarian if you think your pet could benefit from a gluten-free diet. There are many ingredients commonly believed to contain gluten that are actually gluten-free, including quinoa, buckwheat, rice, millet, and maize (corn).   ARE 'GRAIN-FREE' PET FOODS HEALTHIER?
The most important consideration when deciding what diet to feed is whether it provides complete and balanced nutrition. If there is too much of one nutrient and not enough of others, it will impact the pet's health. This principle is true regardless of whether the pet food contains grain or not.
  The best way to ensure a healthy diet is to feed a complete food appropriate to the pet and their life stage. Your veterinary health care team can help select an adequate food for each case. For those that prefer grain-free pet food, there is a good selection of products on the market.   ARE 'GRAIN-FREE' DIETS BETTER FOR PETS WITH ALLERGIES?
While adverse reactions to food do occur in pets, the true prevalence of dietary intolerance or allergy in pets is unknown but thought to be rare. Reports vary, however one review found that cutaneous adverse food reactions (CAFR) – which include allergies as well as intolerances – have a prevalence of between 1-2% of dogs and 0.2% of cats, presented to veterinarians3. It is important to remember that not all allergies are linked to food e.g., fleabite allergy, and it is important to investigate all potential causes with your veterinarian.
  Whilst a very small number of pets, like humans, may be intolerant or allergic to a particular grain, this does not mean that other grains are not tolerated, that all pets will be affected, or that any one grain is inherently bad for the health of pets.
  Available research has highlighted that the most common proven allergens for cats and dogs are protein sources and include beef, chicken, fish, and dairy products4. Owners concerned about dietary intolerances or allergies should always speak to their veterinarian. It is important to work closely with your veterinarian to determine the cause of your pet's allergy. An allergic response can occur to any protein, including those contained in cereals and pulses. Specialized diets are available that are designed for the reduction of food intolerances and allergies.   ARE 'GRAIN-FREE' DIETS LINKED TO HEART PROBLEMS IN DOGS?
The US Food and Drug Administration (FDA) opened an investigation into the occurrence of non-hereditary dilated cardiomyopathy (DCM) in dogs in 2018, when they noted an association between reported cases of DCM and some diets containing a very high proportion of pulses and/or potatoes5,6. Diets reported included both 'grain-free' and grain-containing formulations. In some cases of DCM, a change in diet is part of the treatment as it can result in clinical improvement. Research to examine a potential cause has been inconclusive to date.
  The FDA is also continuing to explore the role of genetics, underlying medical conditions, and/or other factors in DCM. The FDA did not recall any products at any time. In December 2022, FDA issued a statement saying that it does not intend to release further public updates on DCM and diets until there is meaningful new scientific information to share.
  If you have any questions relating to DCM it is recommended that you talk to your veterinarian. Source: FEDIAF
  References
Ingredient Definitions | IPIC – International Pulse Ingredient Consortium (pulseingredients.com). ↩︎
Carbohydrates in dog and cat food | FEDIAF (europeanpetfood.org) ↩︎
Olivry T, Mueller RS. Critically appraised topic on adverse food reactions of companion animals (3): prevalence of cutaneous adverse food reactions in dogs and cats. BMC Vet Res. 2017 Feb;13(1):51. doi: 10.1186/s12917-017-0973-z. PMID: 28202060; PMCID: PMC5311844. ↩︎
Mueller RS, Olivry T, Prélaud P. Critically appraised topic on adverse food reactions of companion animals (2): common food allergen sources in dogs and cats. BMC Vet Res. 2016 Jan 12;12:9. doi: 10.1186/s12917-016-0633-8. PMID: 26753610; PMCID: PMC4710035. ↩︎
FDA Investigation into Potential Link between Certain Diets and Canine Dilated Cardiomyopathy | FDA ↩︎
Questions & Answers: FDA's Work on Potential Causes of Non-Hereditary DCM in Dogs | FDA ↩︎

Holistic Stability with Functional Ingredients and Real Value
Formulation

5+ MIN

Holistic Stability with Functional Ingredients and Real Value

3A BIOTECH and Real Value: You Don't Buy It, You Protect It
The value of a raw material is not defined only by its specification sheet, but by its ability to remain stable over time. Pet food is a living system, exposed to chemical changes, sensory alterations and microbiological hazards during processing, storage and transport—and finally when the pack is opened at home. Throughout that journey, stability determines whether the formulation delivers on its promise.

How to Prevent Loss of Real Value    
Fats and oils, meals and proteins are core pillars of metabolisable energy, palatability and the supply of essential nutrients. At the same time, they are the components most vulnerable to degradation. Lipid oxidation generates free radicals and peroxides that damage vitamins and other fat-soluble compounds, alter aroma and reduce the food's actual bioavailability. These processes begin as soon as the raw material is exposed to air and continue throughout the entire shelf life.

The consequences are direct: a drop in real energy delivery, loss of palatability, the formation of undesirable secondary compounds and reduced aroma stability. In practice, the lipid profile the animal consumes may no longer match what is declared. That is why oxidative stability is a central parameter of real value: if an ingredient oxidises easily, its nutritional and functional value diminishes long before it reaches the consumer.

Moreover, oxidation is not only a sensory issue. Certain compounds derived from rancidity can contribute to digestive imbalances. In pet food—where tolerance and the microbiome matter—protecting against oxidation also protects the nutritional experience.
3A BIOTECH and Microbiological Safety: The Other Pillar of Real Value
Alongside oxidative loss comes microbiological instability. Animal-origin raw materials and certain cereals can promote the growth of moulds and bacteria if not properly controlled. The challenge is compounded by the potential presence of heat-stable mycotoxins, which can survive processing and compromise final product safety.

Even moderate microbial loads can accelerate degradation and shorten shelf life in ways that are not immediately visible. For that reason, microbiological quality is a critical component of real value: it determines safety, stability and formulation performance, and it also influences batch-to-batch consistency.

Beyond Price: Technological Efficiency and Functional Value 
In a market that has historically competed in cost, more and more manufacturers recognise that differentiation is not only about purchase price, but about true functional value: what an ingredient delivers, what it preserves, and what it guarantees. Evaluation moves beyond '€/tonne' and starts to include stability, digestibility, control of wastage, sensory consistency and fewer issues/complaints.

This evolution reflects a more demanding end consumer seeking premium, natural products with tangible benefits. It also pushes the industry towards integrated systems that not only protect raw materials but also provide technological and biological functionality.
3A BIOTECH Functional Ingredients: Protect, Complement, Optimise
A functional ingredient—typically natural in origin, derived from plants, microorganisms or bioactive extracts—provides additional benefits either to the organism or to the formulation itself. In pet food, this translates into improvements, such as gut-health support, immune reinforcement, oxidative stabilisation, microbiota modulation, cellular protection against oxidative stress, and improved digestibility.

From a technological perspective, functional ingredients extend product stability, preserve organoleptic integrity and reduce degradation during storage. They can also help optimise texture, stabilise emulsions, minimise unwanted reactions and support preservation, by reducing variability and enabling more consistent nutritional claims.
Holistic Stability with 3A BIOTECH: Antioxidants + Preservatives, By Design
To preserve real value, the industry relies on carefully designed antioxidant and preservative systems. Antioxidants work by preventing free-radical formation and protecting lipid integrity. In parallel, preservatives based on organic acids help keep microbial loads under control, avoiding deterioration that would reduce the initial nutritional value.

When these systems are formulated with an integrated approach—synergy, correct dosing and process compatibility—they stop being 'additives' and become functional ingredients: they influence stability, safety and overall formula performance.
3A BIOTECH in Dry and Wet: Two Challenges, One Goal
In dry foods, the risk of rancidity increases when oxidation-susceptible meals are combined with oils applied as coatings. Processing and storage time can intensify degradation, affecting aroma, flavour and acceptance by the animal.

In wet foods, although wax coatings can help minimise drying out—particularly relevant for cats due to their more fragmented feeding pattern—it remains essential to stabilise emulsions and control oxidative and microbiological degradation. Here, emulsion physical stability is key to maintaining texture, appearance and palatability: small variations can trigger defects visible to the consumer.
3A BIOTECH TOCOTYROSOL: Stability + Functionality in One Solution
A balanced combination of antioxidant protection and functional support is found in formulations such as TOCOTYROSOL by 3A BIOTECH. This solution is developed using natural antioxidants—tocopherols and extracts of rosemary, olive and green tea—and is designed to integrate efficiently into manufacturing processes for both dry and wet foods.

Its antioxidant synergy helps preserve sensory and nutritional stability from production through to consumption, supporting lipid profile integrity, palatability and product consistency. In addition, it incorporates a prebiotic angle that supports the intestinal microbiota and digestive efficiency, aligning with the growing demand for more functional formulations.

From the manufacturer's perspective, these solutions deliver value at the technological stage (oxidation control, stability, preservation and reduced variability) and help sustain formulation performance over time. In other words, they enable the final product to fulfil the brand promise—batch after batch.
Conclusion: Raw Material, Real Value
The pet food industry no longer competes to be the cheapest, but to be the most efficient, stable and functional. In a sector where every ingredient is an investment, ensuring raw materials retain their real value is a strategic decision: it improves final quality, reduces issues and strengthens consumer trust.

At 3A BIOTECH, we help brands protect that value with natural solutions based on functional ingredients and holistic stability systems. 

Would you like to validate it on your own line? Request a technical assessment or a pilot trial with TOCOTYROSOL and see how well-designed protection can translate into greater stability, a better consumption experience and a more consistent product. By 3A BIOTECH
Source: All Pet Food Magazine

The Supplement Problem No One Is Talking About
 
Other microingredients

9+ MIN

The Supplement Problem No One Is Talking About  

A recent study published made me sit with that question a little harder. In the study, researchers tested 70 over-the-counter canine and feline dietary supplements purchased from a major online retailer, analyzing each for five essential minerals and 12 heavy metals. They also compared actual mineral concentrations to label claims for any product that made them.
  The headline finding is that none of the supplements exceeded the National Research Council (NRC) Maximum Tolerable Levels (MTLs) for any mineral, including the heavy metals tested. That's worth saying, because this isn't a product safety recall story. But when you read past the headline, the bigger picture is more complicated and more relevant to anyone building or scaling in this category.   What the Data Actually Shows   Across all 70 products, the researchers recorded 376 heavy-metal detections. Only one product contained no detectable heavy metals. Every other product in the study (69 out of 70) had at least one.
  The most prevalent heavy metal was nickel, found in 66 of 70 products (94.3%), followed by barium in 64 products (91.4%) and vanadium in 61 products (87.1%). Lead was detected in 16 supplements (22.9%), with concentrations of up to 3.7 mg/kg. Cadmium was detected in 10 products (14.3%), with concentrations up to 1.5 mg/kg. Arsenic was found in 19 products (27.1%).
  These aren't trace amounts you have to squint to find. They're present because heavy metals enter the supply chain through natural mineral contamination of raw ingredients, including soil, water, and plant material. Without robust ingredient specification and testing, they pass straight through into the finished product.
  One finding in particular stuck with me. A product explicitly marketed for liver support, with claims to help the animal's body avoid exposure to heavy metals, contained five detectable heavy metals: vanadium, chromium, cobalt, nickel, and barium. That's not a safety violation; it's a credibility problem. And it illustrates what can happen when formulation and quality control aren't working in sync, and why heavy metal testing needs to be a deliberate, standalone part of a brand's quality program. Guaranteed analyses and standard label claim verification don't screen for heavy metals. That requires proactive, targeted testing at the ingredient and finished-product levels, something most brands aren't doing unless they've built it explicitly into their quality protocols.     The Selenium Story Is Its Own Warning   The essential mineral findings deserve their own attention. Selenium is an essential nutrient, but it has one of the narrowest margins of safety of any mineral in companion animal nutrition. The selenium maximum for dogs set by the Association of American Feed Control Officials (AAFCO) is 2 mg/kg dry matter, which isn't far above the minimum required amount of .35 mg/kg. The present study found selenium in 52 of 70 products (74.3%), with concentrations up to 14 mg/kg supplement, as-fed.
  What matters is that selenium was only declared as an added ingredient in 10 of those 52 products. The other 42 contained selenium that pet owners, and probably most formulators, would have no reason to expect to be there.
  The authors flag a specific scenario worth thinking through. If a small dog or cat is consuming a primary diet that meets the AAFCO selenium minimum and is also receiving a supplement containing meaningful selenium concentrations, the total daily intake can exceed the AAFCO maximum. The concern scales upward for smaller animals because supplement dosing is based on body weight, but calorie requirements, and therefore primary food intake, scale to metabolic body weight. A 4.5-kg cat consuming a selenium-containing supplement at the label dose can end up in a different risk category than a 30-kg dog consuming the same product.
  And then there's the stacking question. The authors cite a survey in which 66% of dogs receiving supplements were receiving more than one supplement simultaneously. Their analysis assumed a single supplement was being used. Add a second or third product, and the cumulative mineral picture changes meaningfully.   The Miss Rate Is Real   The label accuracy findings are worth noting, too. Of the 18 products that made quantitative claims for one or more of the minerals analyzed, eight of them (44%) failed to meet at least one label claim. Of those eight, 87.5% were multivitamin/mineral supplements.
  Of the 53 total label claims across those products, 77.4% were met or exceeded. That sounds reasonably good until you look at what 'exceeded' sometimes means: seven products had detected concentrations of at least 200% of the claimed content. One contained 331% of its claimed iron. Another contained 443% of its claimed zinc. On the other hand, three products had less than 60% of the claimed content for at least one mineral.
  Those numbers matter beyond the spreadsheet. Chronic excess zinc intake in dogs can cause hemolytic anemia, liver and pancreatic damage, and acute kidney failure. The tricky part is that supplement-sourced overexposure tends to creep up slowly. A pet owner who's diligently giving their dog a daily joint chew has no reason to suspect the product is delivering more than four times the zinc on the label. By the time clinical signs appear, the damage may already be underway. On the flip side, three products had less than 60% of their claimed content for at least one mineral, meaning some pets aren't getting anywhere near the therapeutic dose the supplement was purchased to deliver.
  This isn't a new problem. Research has documented label inaccuracies in pet supplements for years. One study found that 84% of chondroitin sulfate products deviated from their label claims, with deviations ranging from 0% to 115%. What the present study adds is current, systematic data across a broader supplement category.
  The practical takeaway is straightforward. A label claim is not a quality assurance system. It's a starting point that requires independent verification to be meaningful.   The Feline Problem Within the Problem   Something the study surfaces quietly, but that deserves louder attention in our industry, is that we don't have species-specific MTL data for cats. The NRC has established canine MTL values only for cadmium and lead. For cats, there are no NRC MTL values for any of the minerals analyzed in this study. The researchers had to apply the same MTL values to both cat and dog data, and where species-specific values didn't exist, they used MTL derived from rodents, poultry, or swine.
  The authors are candid about the limitations. For cats, they note that comparisons to omnivore livestock species are particularly weak because cats are obligate carnivores. Better reference points might be mink or other fur-bearing carnivores, for which essentially no data on tolerable levels exist.
  This matters for two reasons. First, cats metabolize many compounds differently from dogs, which means that certain compounds clear more slowly, while chronic low-level exposures can accumulate in ways that wouldn't be predicted from dog or human data. Second, the cat supplement segment is growing faster than any other pet type in the category. MarketsandMarkets projects a 9.1% CAGR for cat supplements through 2030. Increased use of feline supplements against a backdrop of inadequate feline-specific safety data is a dangerous combination that the industry should be paying attention to.   Why NASC Matters   This is the part of the conversation I want to spend more time on. And I'll be honest, quality claims in the pet supplement space can feel like shades of grey. 'Tested,' 'verified,' 'third-party certified' get applied so loosely that they've largely lost meaning. That credibility gap is real and worth naming. What separates a genuine quality infrastructure from a marketing badge is whether it creates verifiable, auditable accountability at the points where things actually go wrong: ingredient sourcing, manufacturing consistency, label accuracy, and post-market safety surveillance.
  The National Animal Supplement Council (NASC) Quality Seal is consistently misunderstood as a marketing badge rather than a quality-infrastructure requirement. However, the supplement findings in this study are exactly the failure modes the NASC process is designed to catch. It cannot be prevented entirely, because no system eliminates all risk, but it can detect, track, and correct.
  To earn the NASC Quality Seal, a company must pass a comprehensive independent third-party audit, a process that typically takes about four months from start to finish. The audit covers documented standard operating procedures for production process controls, labeling compliance against NASC guidelines, and verification that products are registered in the NASC adverse event reporting database. The audit certificate must be renewed every two years; there's no grandfathering. Companies must also pass random independent product testing to verify that what's on the label is what's in the product.
  Run the study findings through that framework. Selenium showing up undeclared in 74% of products? That's an ingredient specification and testing failure that an audit-ready quality control system would catch. A product claiming 443% of its labeled zinc? That's a batch-level manufacturing inconsistency that random independent testing would surface. A liver support product containing multiple heavy metals despite marketing language around metal avoidance? That's a formulation and claims review failure that NASC's labeling compliance process exists to prevent.
  None of this means NASC certification guarantees perfection, but it creates accountability structures that the unregulated default does not.   The Business Case for Getting This Right   Here's what I've seen work when working with supplement brands at different stages. Quality infrastructure tends to get treated as a later-stage problem. First, you build the product, establish distribution, and prove the market, then you worry about audits and SOPs. That sequencing creates real downstream risk.
  Veterinary channel access is increasingly quality-credential-dependent. Retailers are asking harder questions about third-party testing, and the conversation happening in the research community right now will reach the retail floor and the veterinary exam room faster than most brands anticipate.
  There's also a differentiation argument that isn't made often enough. This study, and the broader literature it builds on, create a genuinely useful commercial conversation for any brand that has done the work. In a market where 69 out of 70 randomly selected products contain at least one detectable heavy metal and nearly half of quantitative label claims on multivitamin products don't fully hold up, transparency is a competitive position. A brand that can point to its NASC audit certificate, its independent testing Certificates of Analysis (CoAs), and its ingredient-level heavy metal specifications is telling a fundamentally different quality story than one that can't.
  The challenge, and I hear this regularly, is that building the quality infrastructure and the product simultaneously, while managing a launch, feels overwhelming. But, it doesn't have to be. The NASC audit process is structured and learnable. Ingredient specification development and supplier qualification don't require a large internal team if you're approaching them systematically. And the investment in getting it right early is considerably smaller than the cost of fixing it later.   What I'd Be Asking If I Were You   If you're currently selling supplements: When did you last run independent testing on your current formulations? Does your CoA come from your manufacturer or from an independent lab? Do you have heavy metal specifications written into your ingredient purchasing agreements?
  If you're developing a new supplement line: Are your formulation decisions and your quality control (QC) infrastructure decisions happening in parallel, or sequentially? Have you mapped your label claims against independent verification?
  If you're thinking about the feline category specifically: Are you applying dog-centric safety assumptions to a species that metabolizes compounds meaningfully differently, with essentially no species-specific tolerable level data to lean on?
  This study doesn't say the sky is falling. It says we're building a multi-billion-dollar category on a quality foundation that hasn't been fully validated. The data to start asking harder questions is now clearly in the literature. The frameworks to start answering them, starting with NASC, already exist.
  The questions this study raises don't have easy answers, but they do provide a starting point. If you want to go deeper into the regulatory and quality aspects of supplement formulation, BSM Partners' team recently covered much of this ground in our podcast episode "Wrangling the Wild West of Pet Supplements" with Dr. Stephanie Clark and Jordan Tyler. And if your brand is actively navigating supplement quality, NASC audit readiness, or label compliance, that's exactly the kind of work our FSQAR practice was built for. We help clients build the quality infrastructure that makes those questions answerable, before they become problems. By Neeley Bowden Lewis
Source: BSM Partners

Inflexible Formulations: What Vitamin & Amino Acid Supply Disruption Could Mean for Pet Food
 
Vitamins

3+ MIN

Inflexible Formulations: What Vitamin & Amino Acid Supply Disruption Could Mean for Pet Food  

Recent discussions around vitamin and amino acid supply chains highlight a critical issue: these nutrients are not optional in pet food. Like the animal protein sector, they are foundational to animal health, but for pet food they are also integral to product integrity and regulatory compliance. For the pet food sector, even small disruptions can have outsized impacts.   The Nutritional and Formulation Challenge
Pet food is governed by strict nutrient requirements. In the U.S., dog and cat foods must meet defined nutrient profiles that specify minimum levels of essential vitamins and amino acids per pound of product. This means formulation is not simply about substituting ingredients; it is about maintaining precise nutritional balance. When supply disruptions occur, nutritionists are forced into complex reformulation decisions, which I describe as, 'solving a Rubik's Cube' -- adjusting one component inevitably affects multiple others. 
  Ingredient shifts can alter digestion, stability and overall product performance. When key vitamins or amino acids become scarce, manufacturers may need to modify formulations, and those changes carry real risk. Nutrient imbalances may impact gut health, skin and coat quality or long-term wellness. Changes in ingredient composition can also affect palatability and food intake, which pet owners will quickly notice. At the same time, reformulations may jeopardize label claims, certifications or even patented formulations. 
  Pets, particularly cats, have unique nutritional requirements that heighten the stakes of supply disruption. Taurine, for example, is essential for cats, and inadequate levels can lead to serious health conditions such as dilated cardiomyopathy. Nutrient interactions, such as those involving thiamine and amino acid balance, can create cascading formulation challenges. Certain dog breeds also require careful amino acid fortification to avoid health complications. These sensitivities mean that even temporary shortages can have real biological consequences if not managed carefully. 
  The risks become even more pronounced in veterinary therapeutic diets, which are designed as part of a broader health management plan; for example, renal diets for kidney support. When supply disruptions force the use of alternative or endogenous nutrient sources, unintended consequences may arise, including the introduction of unwanted co-nutrients, reduced bioavailability or conflicts with the intended therapeutic outcome. In these cases, formulation changes are not just technical, they are clinical decisions with direct implications for animal health. 
  Alternative ingredient strategies often rely on endogenous sources or complex co-products. While these can help bridge supply gaps, they introduce new uncertainties around nutrient availability, digestibility and additional nutrients that must be managed. In pet food, even small ingredient swaps can significantly alter the overall formula, increasing the risk to product design and performance.    A Supply Chain Issue with System-Wide Implications
One of the most important realities is that pet food does not operate in isolation. The same supply chains that support livestock production and human nutrition also supply companion animal diets. 
  As a result, disruptions in vitamin and amino acid production affect multiple sectors simultaneously. Increased costs or limited availability upstream in protein production ultimately translate into higher costs and tighter constraints downstream in pet food. This interconnectedness underscores a broader point: pet food is part of a larger food security system in North America. 
  While rising costs are a concern, the more fundamental challenge is maintaining supply stability. Pet food formulations are not easily or frequently changed due to regulatory requirements, labeling and packaging constraints, product claims and certifications and intellectual property considerations. Because of these constraints, the industry cannot simply adjust on the fly. Stability in ingredient supply is essential to maintaining consistent, safe and compliant products. 
  Ensuring a stable supply of vitamins and amino acids is critical to the future of the pet food industry. This will require coordinated efforts across agriculture, ingredient manufacturing and regulatory systems. Without that stability, the industry faces increasing pressure on formulation integrity, product performance and ultimately animal health. 
  The question is not just how to respond to disruption, but how to build a more resilient supply chain that supports pets, producers, and consumers alike.  Source: IFEEDER

Symrise Invests in Bond Pet Foods to Accelerate Sustainable Innovation in Pet Nutrition Via Precision Fermentation
 
Proteins

2+ MIN

Symrise Invests in Bond Pet Foods to Accelerate Sustainable Innovation in Pet Nutrition Via Precision Fermentation  

Symrise today announced a strategic equity investment in Bond Pet Foods, a U.S.-based biotechnology company that uses precision fermentation to produce animal-identical proteins complementing the existing pet food portfolio of Symrise. The partnership supports Symrise's ambition to develop biotech-enabled ingredients that work better for pets and the planet, strengthening the long-term competitiveness and sustainability leadership of Symrise Pet Food.
  With this partnership, Symrise will leverage Bond Pet Foods' technology to help address key industry challenges, including supply-chain continuity and growing consumer demand for sustainable products that diversify the source of pet food ingredients. For pet food manufacturers, the collaboration aims to broaden access to high-quality proteins while supporting resilience and responsible sourcing.
  'This investment marks an important step in advancing our strategy to develop next-generation sustainable ingredients with biotechnology. By combining Bond's fermentation capabilities with Symrise's application expertise and market insight, we can deliver high-performance nutrition solutions and create new growth opportunities for our customers,' said Diego Maurizio, General Manager, Palatability & Nutrition Business Line at Symrise.
  Founded in 2017, Bond Pet Foods develops animal-identical proteins for pet nutrition using precision fermentation. The company has progressed its platform through several development agreements, building expertise in bringing novel protein ingredients toward real-world application.
  'We have put great effort into building a new way to produce animal-identical proteins for pet food applications. Now, we find it exciting to see that work gaining traction across the industry", said Rich Kelleman, CEO of Bond Pet Foods. "Partnering with Symrise marks an important step forward bringing their deep expertise in pet nutrition and taste to further expand how our ingredients perform and can be used by pet food manufacturers,'
  "This investment advances our ambition to scale biotechnology across our business. With this, we aim at effectively supporting long-term resilience, portfolio diversification, and a stronger innovation pipeline", says Walter Ribeiro, President Taste, Nutrition & Health at Symrise. "By helping our customers develop more sustainable pet food formulations, the collaboration reinforces Symrise's sustainability commitments and consumer-driven innovation strategy." Source: Symrise AG
About Bond Pet Foods Bond Pet Foods is a Boulder, Colorado-based company using precision fermentation to produce animal-identical proteins for the pet food industry. By combining yeast fermentation with food science, Bond creates high-quality animal-identical proteins that meet the nutritional needs of dogs and cats, while supporting a more sustainable and resilient food system.
  Bond supplies these ingredients to pet food manufacturers for use in food, treat, and supplement applications.
  The company's investors include leading funds and organizations across the biotechnology, ingredient, and pet nutrition sectors, including Genoa Ventures, Lever VC, ADM Ventures, Cavallo Ventures (Wilbur-Ellis), Agronomics, Thia Ventures, KBW Ventures, iSelect Fund, Stage 1 Fund, Plug and Play Ventures and Symrise North America. www.bondpets.com


Palatants

Palatants  Leveraging Artificial Intelligence to Predict Pet Food Palatability

2+ MIN

 Leveraging Artificial Intelligence to Predict Pet Food Palatability

WHY THIS MATTERS
Palatability is one of the strongest drivers of product success in pet food. Yet, predicting it remains challenging. Development still relies heavily on iterative animal trials, which are time-consuming, costly, and often identify failures late in the process.
  At AFB, we are changing this approach by using artificial intelligence (AI) to predict palatability outcomes before testing. By combining historical data with formulation knowledge, we help transform development from trial-and-error into a more targeted and efficient process.
  THE CHALLENGE
Palatability is the result of multiple interacting factors, including ingredients, inclusion levels, fat systems, processing, and animal variability. These interactions are complex and non-linear, making outcomes difficult to anticipate.
  Because of this complexity, traditional approaches struggle to efficiently explore formulation space and consistently deliver high-performing solution.   A NEW APPROACH: FROM TESTING TO PREDICTING
Instead of relying only on experiments, we integrate data across trials and formulations to identify patterns and predict outcomes.
  Our models transform inputs such as recipe composition, ingredient levels, and processing conditions into clear guidance: which solutions are most likely to succeed and which carry higher risk.
    FROM DATA TO DECISIONS
Our approach converts complex datasets into practical insights that guide development. Rather than focusing only on performance, we also consider how reliable each result is.
  By combining performance with confidence, we generate a clear prioritization of what to test next. This allows teams to focus on the most promising formulations and avoid unnecessary trials.
    WHAT THIS ENABLES

This predictive approach allows us to:
  Identify high-potential solutions earlier Reduce experimental burden Focus on the most impactful ingredients Improve consistency of results
  In practice, large experimental spaces can be narrowed down to a smaller set of high-confidence candidates, accelerating development and improving outcomes.   A SMARTER WAY TO DEVELOP PALATANTS
Artificial intelligence does not replace expertise—it enhances it. Scientific knowledge remains central to interpretation and validation, while predictive models help guide decisions and reduce uncertainty.
  By combining data, science, and AI, we enable a more efficient and confident approach to palatability development. Source: AFB International

Proteins Unlock Innovative Possibilities in Wet Pet Food Formulation with the Power of Faba Bean Protein

4+ MIN

Unlock Innovative Possibilities in Wet Pet Food Formulation with the Power of Faba Bean Protein

Demand for wet pet food is on the rise, with the segment's growth being driven by pet owners looking for premium and nutritionally balanced pet food with good palatability.i At the same time, consumers increasingly want to see more plant-based offerings that also reflect their own sustainability values. In response to these evolving expectations, BENEO has conducted a new set of technical trials to explore the potential of its faba bean protein concentrate as a functional, plant-based ingredient for wet pet food.
Exploring Alternatives to Animal Blood Plasma
In premium and super-premium wet pet food, maintaining consistent product quality is essential. These products typically contain at least 50 wt% total moisture, and their quality is standardised and maintained through the addition of spray-dried animal blood plasma (ABP). This ingredient provides excellent texturizing and emulsifying properties but can come at a high cost. Moreover, due to its animal origin, ABP is increasingly perceived as undesirable by consumers who increasingly want more plant-based ingredient options for their pets.
  To address these challenges, BENEO initiated a series of technical trials in collaboration with Passion4Food, a specialist service provider for the pet food industry. The objective was to evaluate whether faba bean protein concentrate could be used as a suitable and cost-effective alternative to ABP in wet pet food formulations.
Technical Trials Confirm Strong Functional Performance
The initial trials investigated the performance of BENEO's faba bean protein concentrate when partially (50%) or fully (100%) replacing ABP in high-protein wet pet food loaves (paté format). The results showed that the ingredient could be successfully used for both full and partial ABP replacement, with no significant change in the end product's weight or texture. This means producers can maintain desired product quality while achieving considerable cost savings compared to ABP. Based on these promising results, BENEO carried out follow-up trials using a test recipe suitable for commercial scalability.  

As part of the following additional trials, the same percentages of ABP and faba bean protein concentrate were used and compared to a test recipe in which ABP was partially replaced at 50% with pea protein concentrate.
  The data demonstrated that BENEO's faba bean protein concentrate acted as an excellent and cost-effective alternative binder to ABP, with no significant changes observed in loaf height, weight, hardness, or adhesiveness. In contrast, the partial replacement of ABP with pea protein concentrate led to a significant decrease in hardness, indicating that faba bean protein concentrate provides a higher binding capacity in wet pet food loaves. This makes it a valuable ingredient for maintaining the desired texture of the end-product while reducing reliance on animal-derived binders.  
Patent Application Supports Scientific Innovation
Following these successful results, BENEO filed an international patent application for the use of faba bean protein concentrate as an alternative to spray-dried animal blood plasma in wet pet food. The patent application was published in August 2025, underscoring BENEO's dedication to research-based innovation and functional ingredient development for the pet food industry.
Nutritional and Formulation Advantages
Beyond its technical and cost benefits, BENEO's faba bean protein concentrate also provides strong nutritional value. With a protein content of 61 g per 100 g on a dry matter basis and an ileal digestibility score of almost 90%, it is a highly digestible source of protein. Its amino acid profile is relatively rich in lysine and can complement cereal proteins, such as rice protein or vital wheat gluten, to achieve a complete essential amino acids profile.

The ingredient also provides flexibility for product positioning. It is listed in the EU Catalogue of Feed Materialsii and can be used in formulations that carry 'no grain' claims.
Contributing to Sustainable and Locally Sourced Solutions
Sustainability has become an increasingly important consideration for both consumers and producers. BENEO's faba bean protein concentrate offers strong sustainability credentials linked to the faba bean crop and to BENEO's local sourcing and production processes in Germany. Local production in the new state-of-the-art pulse-processing plant, located in Obrigheim, further supports short transport distances, secures supply and reduces the environmental impact compared to more resource-intensive ingredients.
  Dr Maygane Ronsmans, Product Manager Animal Nutrition at BENEO, comments:

'With two in three pet owners considering plant-based proteins to be better for the environmentiii, demand has grown for sustainable and locally sourced vegetal protein ingredients. As the technical trials show, BENEO's faba bean protein concentrate offers pet food manufacturers a win-win scenario: producers can decrease their recipe costs while benefitting from secure supply and meeting consumer expectations for more sustainable and plant-based pet foods, without impacting the quality of the end-product.'
Supporting the Next Generation of Wet Pet Food Innovation
The findings from BENEO's trials confirm that faba bean protein concentrate combines functionality, nutritional quality and sustainability. It performs effectively as a binder in wet pet food, delivers a high level of digestible protein, and provides a viable alternative to animal blood plasma in applications where consistency and texture are key.
  For pet food manufacturers, this opens the door to new formulation strategies that balance technical performance, cost efficiency and environmental responsibility. As the market continues to evolve, ingredients such as BENEO's faba bean protein concentrate can help producers meet consumer expectations for more plant-based, locally sourced and high-quality products.
  Interested in learning more about BENEO's ingredient solutions? Find more details here  By BENEO
Source: All Pet Food Magazine References
i Wet Pet Food Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035, Future Market Insights Inc, 2024. 
ii Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials – Faba bean protein concentrate is listed under entry 3.7.5: 'Horse bean protein' 
iii BENEO Consumer Research On Pet Care 2025. FMCG Gurus conducted a quantitative online survey in 2025 with 2.500 pet owners in the US, Brazil, UK, Germany, and China (250 cat and 250 dog owners per country).


Formulation

Formulation <em>Gleditsia Amorphoides</em> as a Source of Saponins and Bioactive Compound for Pet Food

6+ MIN

Gleditsia Amorphoides as a Source of Saponins and Bioactive Compound for Pet Food

Gleditsia amorphoides   In recent years, new plant-based sources of saponins have been investigated to expand the functional benefits of these compounds, with Gleditsia amorphoides emerging as a promising alternative. This tree species, belonging to the Fabaceae family, is native to temperate and subtropical regions and has traditionally been used for timber and industrial purposes. Gleditsia amorphoides presents a high saponin content (approximately 22%, compared to 7–15% in Yucca schidigera) and a relevant profile of bioactive compounds, including galactomannans and polyphenols (Perduca et al., 2013; Lu et al., 2024).

Although studies are still limited, initial evidence—mainly from in vitro experiments—suggests that gleditsia extract can modulate the intestinal microbiota by promoting saccharolytic bacteria, reducing microorganisms associated with proteolytic fermentation, and increasing the production of metabolites with antioxidant and anti-inflammatory potential (Francis et al., 2002; Sparg et al., 2004; Sittikijyothin et al., 2005). To further investigate this potential, a study was conducted in adult dogs to evaluate the effects of dietary supplementation with Gleditsia amorphoides and Yucca schidigera extracts on intestinal fermentation, fecal metabolites, and systemic biomarkers related to inflammation and antioxidant status.   Gleditsia amorphoides
Source: Wikimedia Commons   Study on Gleditsia amorphoides in Dogs
Materials and Methods The study was carried out at the canine nutrition laboratory (LENUCAN) at the Federal University of Parana (UFPR) in Brazil and was approved by the institution's Animal Ethics Committee (protocol no. 013/2024). Eighteen healthy adult beagle dogs (10 males and 8 females), approximately two years old and with an average body weight of 12.2 ± 1.33 kg, were randomly assigned to three experimental groups (six dogs per group): control (unsupplemented diet), diet supplemented with 200 g/ton of Yucca schidigera extract, and diet supplemented with 200 g/ton of Gleditsia amorphoides extract (Sapcor®, Bioaromas do Brasil)  Diets differed only in the inclusion of the additives. Dogs were fed experimental diets twice daily for 20 days.

At the end of the experimental period, fresh fecal samples were collected to evaluate fecal characteristics and metabolites associated with intestinal fermentation. Fasting blood samples were also collected to assess systemic physiological responses to dietary treatments. Data were analyzed using analysis of variance (ANOVA), followed by Tukey's test when significant differences were identified. Non-parametric data were evaluated using the Kruskal–Wallis test, considering statistical significance at p < 0.05.
Results
No adverse reactions to feeding—such as vomiting, diarrhea, or feed refusal—were observed during the experimental period, indicating good acceptance.
Intestinal Fermentation Metabolites
Dietary supplementation with Gleditsia and Yucca influenced several metabolites associated with intestinal fermentation (Table 1). Dogs fed diets containing Yucca schidigera or Gleditsia amorphoides showed lower fecal ammonia concentrations compared to the control group (P < 0.05), suggesting reduced proteolytic fermentation in the gut. However, only dogs supplemented with Gleditsia showed: more fecal concentrations of propionate, higher total short-chain fatty acids (SCFA), and lower concentrations of 4-methylvalerate compared to the Yucca group (P < 0.05).

Propionate is a characteristic metabolite of saccharolytic fermentation and has been associated with potential anti-inflammatory effects in the gastrointestinal system, including inhibition of the Toll-like receptor 4 accessory protein CD14. This results in reduced activation of NF-κB-mediated inflammatory pathways and decreased production of pro-inflammatory cytokines (Hoyles et al., 2018).
  Table 1 – Mean fecal concentrations (dry matter basis) of ammonia, short-chain fatty acids (SCFA), and branched-chain fatty acids (BCFA) in dogs from Control, Gleditsia, and Yucca groups.
  Note: SEM: Standard error of the mean. P: Probability.
a,b Different letters indicate statistical difference according to the Tukey test (P < 0.05).
  Additionally, fecal concentrations of histamine and spermidine were lower in the Gleditsia group compared to the control group (P < 0.05, Figure 1). These compounds are derived from microbial amino acid degradation and are associated with proteolytic fermentation, which may exert harmful effects on intestinal mucosa and liver function when present at high concentrations (Brito et al., 2010; Souza et al., 2025).   a,b Different letters indicate statistical difference according to the Tukey test (P < 0.05).
Figure 1: Fecal concentrations (dry matter basis) of biogenic amines in dogs from Control, Gleditsia, and Yucca groups.
These effects may be related to the composition of Gleditsia extract, which combines triterpenoid saponins with galactomannans that may exert prebiotic activity (Lu et al., 2024). This combination may promote a shift in microbial fermentation patterns—from predominantly proteolytic to more saccharolytic pathways—as also suggested by in vitro studies using human fecal microbiota exposed to Gleditsia extracts (Wang et al., 2023). Furthermore, saponins may contribute to the reduction of proteolytic metabolites through different mechanisms, including inhibition of bacterial urease activity, direct binding to nitrogenous compounds, and modulation of the intestinal microbiota (Dos Reis et al., 2016; Zhang et al., 2023).
Systemic Biomarkers
Dogs receiving diets supplemented with Gleditsia amorphoides or Yucca schidigera showed: lower lipid peroxidation (LPO) and higher catalase (CAT) activity compared to the control group (P < 0.05, Figure 2), indicating improved antioxidant status. Additionally, dogs in the Gleditsia group showed lower alkaline phosphatase activity compared to the control group (Control: 45.10 U/L; Gleditsia: 33.30 U/L; P < 0.05). These systemic effects may be partially associated with reduced production and absorption of proteolytic metabolites in the intestine, which can trigger inflammatory and oxidative responses (Souza et al., 2025). Additional antioxidant effects may also be linked to polyphenolic compounds present in Gleditsia, such as quercetin derivatives, which have been shown to activate the Nrf2 oxidative stress response pathway in canine hepatocyte cultures (Lu et al., 2024).     a,b Different letters indicate statistical difference according to the Tukey test (P < 0.05).
Figure 2: Lipid peroxidation (LPO, mmol/mL) and catalasa (CAT, mU/mL) in dogs from Control, Gleditsia, and Yucca groups.
Overall, these findings suggest that dietary supplementation with Gleditsia amorphoides may contribute to improving intestinal fermentation patterns and antioxidant status in dogs, indicating potential functional benefits for canine nutrition.
Conclusion
The study conducted at UFPR indicates that dietary supplementation with Gleditsia amorphoides beneficially modulates intestinal fermentation metabolites in dogs. These changes were accompanied by improvements in systemic antioxidant markers, including reduced lipid peroxidation and increased catalase activity. Overall, these findings suggest that botanical additives containing saponins and associated bioactive compounds may contribute to intestinal functionality and systemic health in dogs. By Vanessa R. Olszewski, Danieli Z. Cypriano and Ananda P. Félix – BioAromas
Source: All Pet Food Magazine
  References
Brito, C., Félix, A., Jesus, R., França, M., Oliveira, S., Krabbe, E., & Maiorka, A. (2010). Digestibility and palatability of dog foods containing different moisture levels, and the inclusion of a mould inhibitor. Animal Feed Science and Technology, 159, 150–155. https://doi.org/10.1016/j.anifeedsci.2010.06.001 
Dos Reis, J. S., Zangerônimo, M. G., Ogoshi, R. C. S., França, J., Costa, A. C., Almeida, T. N., Dos Santos, J. P. F., Pires, C. P., Chizzotti, A. F., Leite, C. A. L., Saad, F. M. O. B. (2016). Inclusion of Yucca schidigera extract in diets with different protein levels for dogs. Animal Science Journal. 87: 1019–1027. https://doi.org/10.1111/asj.12535. 
Francis, G.; Kerem, Z.; Makkar, H. P. S.; Becker, K. The biological action of saponins in animal systems: a review. British Journal of Nutrition, Cambridge, v. 88, n. 6, p. 587–605, 2002. DOI: https://doi.org/10.1079/BJN2002725.
Hoyles, L., Snelling, T., Umlai, U. K., Nicholson, J. K., Carding, S. R., Glen, R. C., McArthur, S. (2018). Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier. Microbiome. 6, 55. https://doi.org/10.1186/s40168-018-0439-y. 
Lu, G., Ren, T., Zhao, Z., Li, B., & Tan, S. (2024). Chemical component differences in the endosperm of Gleditsia species seeds revealed based on comparative metabolomics. Food Chemistry: X, 21, 101060. https://doi.org/10.1016/j.fochx.2023.101060. 
National Research Council (NRC). (2006). Nutrient requirements of dogs and cats. National Academies Press.
Perduca, M. J. et al. Gleditsia amorphoides galactomannans: physicochemical properties and industrial applications. In: RAMAWAT, K. G.; MÉRILLON, J. M. (eds.). Polysaccharides: bioactivity and biotechnology. Cham: Springer International Publishing, 2013.  DOI: 10.1007/978-3-319-03751-6_39-1.
Sittikijyothin, W.; Torres, D.; Gonçalves, M. P. Modelling the rheological behaviour of galactomannan aqueous solutions. Carbohydrate Polymers, Oxford, v. 59, n. 3, p. 339–350, 2005. DOI: https://doi.org/10.1016/j.carbpol.2004.10.005.
Sparg, S. G.; Light, M. E.; Staden, J. Biological activities and distribution of plant saponins. Journal of Ethnopharmacology, Amsterdam, v. 94, n. 2-3, p. 219–243, 2004. DOI: https://doi.org/10.1016/j.jep.2004.05.016.
Souza, R. B. M. S., Fernandes, E. L., Santos, L. N. A., Lima, L. S., Silva, H. L., Putarov, T. C., Oliveira, S. G., Felix, A. P. (2025). Effects of yeast beta-1,3/1,6-glucans on nutrient digestibility, intestinal functionality, and immune and antioxidant variables in growing dogs submitted to spay or neutering surgery. Plos One. 20(9): e0331843. https://doi.org/10.1371/journal.pone.0331843. 
Wang, H., Lai, C., Tao, Y., Zhou, M., Tang, R., Yong, Q. (2023). Evaluation of the enzymatic production and prebiotic activity of galactomannan oligosaccharides derived from Gleditsia microphylla. Fermentation. 9(7), 632. https://doi.org/10.3390/fermentation9070632. 
Zhang, Y., Wang, L., Chen, X., Liu, Y., & Li, J. (2023). Quillaja saponaria extract modulates gut microbiota and reduces proteolytic bacteria in dogs: A dose-response study. Veterinary Microbiology, 276, 109634. https://doi.org/10.1016/j.vetmic.2023.109634. 

Vegetable Origin From Alga to Bowl: Astaxanthin Supports Pet Health 

5+ MIN

From Alga to Bowl: Astaxanthin Supports Pet Health 

Owing to the ongoing anthropomorphism of pets, owners are taking a closer look at what they're feeding their beloved companions. Just as they themselves are opting for healthier and cleaner-label nutrition—and starting to consider the associated environmental aspects—, owners want to ensure that the same standards apply to their pet's meals. This is manifesting as a shift towards providing fresh food or preferentially selecting more natural or organic pet food products.

Overall, the pet food sector is witnessing continuous growth. The market size in Europe is estimated to be worth $55 billion in 2024 and is expected to reach a value of more than $78 billion by 2029 (growing at a CAGR of approximately 7%).1 Next to classic feed compounds, such as grain or meat, novel functional ingredients are gaining traction in this developing market. Many of these components can be both integrated into feed grades as well as pet-friendly nutraceuticals. One example is carotenoids, which are not only known for their vibrant yellow, orange, or red colours, but also for their antioxidant attributes. One carotenoid with a particularly high antioxidant power—110 times more than vitamin E—is astaxanthin. 

In nature, the most abundant source of astaxanthin is a tiny microalga called Haematococcus pluvialis. Although astaxanthin has a long history as an ingredient in human supplements, its beneficial effects were first discovered in the marine world regarding the survival and reproduction rates of salmon. Research on astaxanthin in aquaculture was also the basis for the Swedish company, AstaReal's business. The organisation was the first to produce natural astaxanthin on an industrial level and, as the subject of more than 70 clinical studies on humans and animals, it owns today's most researched astaxanthin brand in the market.
Species-Specific Research
'We wanted to understand what this might mean for different kinds of animals, so we started using the ingredient in trials with cats and dogs,' says Peter Ahlm, Head of Marketing & Sales at AstaReal. Distinct research on targeted animals is indispensable when it comes to developing a safe and efficacious product; effects might vary between species, and it's imperative to optimise the amount of ingredients to be dispensed.

There is a growing body of evidence for various positive effects of natural astaxanthin on pets' health, many of which show a similar pattern to humans. For instance, astaxanthin can support canine mobility, endurance, and muscle recovery; the cardiovascular system; cognitive function; attentiveness and at the cellular level, the mitochondria.2–5 Moreover, natural astaxanthin supplementation in dogs and cats could enhance their innate defence systems and improve both their cell-mediated and humoral immune responses.6,7 Astaxanthin also has shown potential to improve impaired vision due to age-related conditions like cloudy lenses in dogs.8 

'The recorded health effects may seem quite diverse; however, they are all rooted in astaxanthin's unique molecular structure. Due to its linear, polar-nonpolar-polar molecular layout, natural astaxanthin can effectively penetrate and traverse the cell and mitochondria membranes and neutralize reactive oxygen species (ROS) in both the hydrophobic interior and hydrophilic exterior boundaries. In addition to providing better protection to the cells and their powerhouses against oxidative stress, natural astaxanthin also has anti-inflammatory effects that support multiple bodily organs and systems.' -  Behnaz Shakersain, Scientific Affairs Manager at AstaReal.
Scoring with Natural Astaxanthin Options
As neither humans nor animals can produce astaxanthin in their bodies, they can only benefit from its protective functions through nutritional intake. To obtain effective amounts, dogs are generally recommended to be fed 1 mg of astaxanthin per 10 kg body weight, which equates to about two wild King salmon fillets for a beagle or three for a golden retriever per day. Feed or treats rich in astaxanthin might offer an easier and more sustainable solution in many cases. 

Natural algae-derived versions of astaxanthin offer additional advantages, such as higher levels of antioxidant potency. Moreover, algae play an essential role in the planet's ecosystem, and being recognised as a renewable resource resonates strongly with responsible consumers. If algae are cultivated indoors, they can be better protected from environmental harm or contamination, and the yield of astaxanthin-rich algal biomass has a higher quality profile. 

Developing a formula with healthy ingredients is only the first step, according to Peter Ahlm: 'Pet food manufacturers also need to make sure that their product will remain stable and nutritious throughout its intended shelf-life. Bioactive substances are particularly prone to interact with other compounds in multi-ingredient formulations or can degrade during harsh production processes, such as extrusion or pelleting.' 

To minimize such risks and protect the power of astaxanthin, AstaReal uses encapsulation in its animal nutrition brand NOVASTA®. Its recently launched NOVASTA® EB15 can be mixed into pet food or added to supplements and consists of algal flour (32%) encapsulated in rapeseed oil with a final astaxanthin concentration of 1.5%. Due to encapsulation, it can be better incorporated into challenging formulations, such as pellets, meal mixes, and soft chews, which are more likely to be exposed to air at ambient temperature.

If manufacturers are sensitive to the shifting demands of pet parents and are willing to combine health with sustainability trends, they are well set. Algal astaxanthin can play an assisting role in these efforts. Thanks to its antioxidant and multifunctional effects, it naturally supports the well-being of our four-legged friends while stemming from a futureproof source.
Futureproof Feeding
One of today's major challenges is how to feed the planet sustainably. In search of plant-based sources for both human and animals, algae are gaining attention. Algae are relatively easy to cultivate, are nutritious, and being considered as more sustainable than several conventional crops. One precious and health-promoting ingredient that algae offer is astaxanthin. AstaReal derives the carotenoid from the micoralgae Haematococcus pluvialis that are being cultivated indoor in specially designed photobioreactors. The company applies a unique system to reuse the excess heat produced during the algae cultivation process to heat up 2500 apartments in the nearby residential area, aiming to continuously reduce their carbon footprint.   By AstaReal
Source: All Pet Food Magazine
References
1.    Mordor Intelligence. 'Europe Pet Food Market SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS UP TO 2029.' https://www.mordorintelligence.com/industry-reports/pet-food-market-in-europe-industry. Accessed Feb. 23, 2024.
2.    B.M. Zanghi, et al., 'Effects of Postexercise Feeding of a Supplemental Carbohydrate and Protein Bar with or without Astaxanthin from Haematococcus pluvialis to Exercise-Conditioned Dogs,' Am. J. Vet. Res. 76(4), 338–350 (2015).
3.    T. Murai, et al., 'Effects of Astaxanthin Supplementation in Healthy and Obese Dogs,' Veterinary Medicine: Research and Reports 10, 29–35 (2019).
4.    National Center for Biotechnology Information. 'PubChem Patent Summary for US-9820497-B2, Astaxanthin-containing pet foods.' https://pubchem.ncbi.nlm.nih.gov/patent/US-9820497-B2. Accessed Feb. 23, 2024.
5.    J.S. Park, et al., 'Astaxanthin Modulates Age-Associated Mitochondrial Dysfunction in Healthy Dogs,' Journal of Animal Science 91(1), 268–275 (2013).
6.    B.P. Chew, et al., 'Dietary Astaxanthin Enhances Immune Response in Dogs,' Veterinary Immunology and Immunopathology 140(3–4), 199–206 (2011).
7.    J.S. Park, et al., 'Astaxanthin Stimulates Cell-Mediated and Humoral Immune Responses in Cats,' Veterinary Immunology and Immunopathology 144, 455–461 (2011).
8.    W. Wang, et al., 'Antioxidant Supplementation Increases Retinal Responses and Decreases Refractive Error Changes in Dogs,' Journal of Nutritional Science 5, E18 (2016).

Advertising

260x430 260x430 260x430 260x430 260x95